![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Vettermann, Franziska; Suchorska, Bogdana; Unterrainer, Marcus; Nelwan, Debie; Forbrig, Robert; Ruf, Viktoria; Wenter, Vera; Kreth, Friedrich-Wilhelm; Herms, Jochen; Bartenstein, Peter; Tonn, Jörg-Christian und Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic F-18-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 12: S. 2581-2589
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic F-18-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 12: S. 2581-2589
Galldiks, Norbert; Unterrainer, Marcus; Judov, Natalie; Stoffels, Gabriele; Rapp, Marion; Lohmann, Philipp; Vettermann, Franziska; Dunkl, Veronika; Suchorska, Bogdana; Tonn, Jörg C.; Kreth, Friedrich-Wilhem; Fink, Gereon R.; Bartenstein, Peter; Langen, Karl-Josef und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Photopenic defects on O-(2-[F-18]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
In: Neuro-Oncology, Bd. 21, Nr. 10: S. 1331-1338
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Photopenic defects on O-(2-[F-18]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
In: Neuro-Oncology, Bd. 21, Nr. 10: S. 1331-1338
Brendel, Matthias; Schönecker, Sonja; Höglinger, Guenter; Lindner, Simon; Havla, Joachim; Blautzik, Janusch; Sauerbeck, Julia; Rohrer, Guido; Zach, Christian; Vettermann, Franziska; Lang, Anthony E.; Golbe, Lawrence; Nuebling, Georg; Bartenstein, Peter; Furukawa, Katsutoshi; Ishiki, Aiko; Boetzel, Kai; Danek, Adrian; Okamura, Nobuyuki; Levin, Johannes und Rominger, Axel
(2018):
[F-18]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.
In: Frontiers in Aging Neuroscience, Bd. 9, 440
[PDF, 2MB]
Blautzik, Janusch; Kotz, Sebastian; Brendel, Matthias; Sauerbeck, Julia; Vettermann, Franziska; Winter, Yaroslav; Bartenstein, Peter; Ishii, Kazunari und Rominger, Axel
(2018):
Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
In: Journal of Alzheimers Disease, Bd. 65, Nr. 3: S. 781-791
Unterrainer, Marcus; Vettermann, Franziska; Brendel, Matthias; Holzgreve, Adrien; Lifschitz, Michael; Zähringer, Matthias; Suchorska, Bogdana; Wenter, Vera; Illigens, Ben M.; Bartenstein, Peter und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Towards standardization of F-18-FET PET imaging: do we need a consistent method of background activity assessment?
In: EJNMMI Research, Bd. 7
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Towards standardization of F-18-FET PET imaging: do we need a consistent method of background activity assessment?
In: EJNMMI Research, Bd. 7
[PDF, 2MB]
Galldiks, Norbert; Unterrainer, Marcus; Judov, Natalie; Stoffels, Gabriele; Lohmann, Philipp; Vettermann, Franziska; Dunkl, Veronika; Suchorska, Bogdana; Tonn, Jörg-Christian; Kreth, Friedrich-Wilhelm; Fink, Gereon R.; Bartenstein, Peter; Langen, Karl-Josef und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Photopenic Defects On O-(2-F-18-Fluoroethyl)-L-Tyrosine Pet - Clinical Relevance In Glioma Patients.
In: Neuro-Oncology, Bd. 19: S. 152
ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Photopenic Defects On O-(2-F-18-Fluoroethyl)-L-Tyrosine Pet - Clinical Relevance In Glioma Patients.
In: Neuro-Oncology, Bd. 19: S. 152
Unterrainer, Marcus; Fleischmann, Daniel; Lindner, Simon; Brunegraf, Anika; Vettermann, Franziska; Vomacka, Lena; Brendel, Matthias; Rupprecht, Rainer; Belka, Claus; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients.
In: Journal of Nuclear Medicine, Bd. 58
ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients.
In: Journal of Nuclear Medicine, Bd. 58
Unterrainer, Marcus; Vettermann, Franziska; Brendel, Matthias; Holzgreve, Adrien; Lifschitz, Michael; Zähringer, Matthias; Wenter, Vera; Suchorska, Bogdana; Bartenstein, Peter und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Towards standardization of F-18-FET PET imaging: What is the best method for background activity assessment?
In: Journal of Nuclear Medicine, Bd. 58
ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
Towards standardization of F-18-FET PET imaging: What is the best method for background activity assessment?
In: Journal of Nuclear Medicine, Bd. 58